INTRODUCTION
elastosis, [4] and grand mal epilepsy. [5] Tuberous sclerosis was first described by Von
CASE REPORT
Recklinghausen in 1862. The name 'sclerosis tubereuse' was used by Bourneville in 1880 to A 17-year-old girl presented with progressively describe the firm consistency (sclerosis) of the increasing, generalized, mottled pigmentation since protruberances (tuberosus). The term tuberous birth. She also had a history of generalized epileptic sclerosis complex (TSC) is currently used to describe seizures since the age of 3 years, mild global the myriad manifestations due to hamartoma developmental delay, and a learning disorder. The formation in multiple organ systems. [1] patient's family history was notable in that, 3 Dyschromatosis universalis hereditaria (DUH) was first generations of her family had a similar pigmentary reported by Jehikawa and Hiraga in 1933. It has been disorder including her sister, father, 5 out of 7 paternal described almost exclusively in Asian families.
uncles and aunts, and her paternal grandfather. Hereditary genetic defects may play an important role However, there was no family history of other skin in altering melanogenesis, which results in lesions or seizures. pigmentary anomalies.
[2] The reported associations include short stature, high tone deafness, [3] solar On examination, the patient was of short stature with a height of 142 cm. There were multiple, randomly and uniformly distributed, small, irregular, hyperpigmented and hypopigmented macules without atrophy all over the body, including palms [ Figure 1 ], soles, and oral mucosa. She also had multiple angiofibromas on the face [ Figure 2 ], numerous oval, hypopigmented macules all over the trunk, confetti skin lesions, a shagreen patch over the right lumbosacral area, periungual fibromas on the left index finger and right third toe, gingival fibromas, and pitting of dental enamel.
Histopathological examination from the hyperpigmented and hypopigmented macules revealed increased melanin content, and decreased melanin content in the epidermis, respectively. The melanocyte number was normal in both specimens. Neurodevelopmental testing demonstrated mild Definite tuberous sclerosis complex is diagnosed by the presence of either 2 major features, or 1 major feature plus 2 minor features. Probable tuberous sclerosis complex is indicated by 1 major feature plus 1 minor feature. Possible tuberous sclerosis complex is indicated by either 1 major feature, or 2 or more minor features. Our case had 6 major and 3 minor criteria, diagnostic of definite TSC, along with definite features of DUH, which was also present in 3 generations in an autosomal dominant pattern. However, there was no evidence of TSC in her parents or siblings.
Two genetic loci have been identified in TSC. The first gene, tuberous sclerosis complex 1 (TSC 1), maps to chromosome 9, specifically 9q34, and encodes the protein hamartin, which is a tumor suppressor gene. The second gene (TSC 2) maps to chromosome 16, specifically 16p13, and codes for tuberin. TSC 2 acts as a tumor-suppressor gene, and TSC 2 mutations may result in tumors at multiple sites. Hamartin and tuberin act synergistically to regulate cellular growth and differentiation. The deregulation in organogenesis results in hamartomas, which may affect any organ in the body. [7] Dyschromatoses are a group of disorders characterized by the presence of both hyperpigmented and hypopigmented, small, irregular macules. DUH is an autosomal dominant disorder of melanosome synthesis rate or melanosome activity, and not a disorder of melanocyte number. The gene responsible for DUH has been mapped to 6q24.2 to 6q25.2 (OMIM 127500). Since the exact biochemical basis of the gene defect is unknown, the clinician must rely solely on external phenotype. DUH has been reported in association with another rare autosomally inherited pigmentary disorder, Dowling-Degos disease, [8] and also with X-linked ocular albinism. [9] The exact mechanism by which these genetic disorders have occurred simultaneously, has not been elucidated. Autosomal dominant traits can involve only one organ as in DUH. However, many autosomal disorders like TSC can manifest in a number of different systems of the body, called pleiotropy.
To the best of our knowledge, there are no previous reports of TSC with DUH, or any other genetic disorder. Although it is possible that our patient had two genetic disorders due to sheer chance, it is important to record any such association, since it may indicate genetic linkage. The unusual features in our case were the involvement of palms, soles, and oral mucosae.
